4.7 Review

Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2022.872759

关键词

vimentin (intermediate filaments); acute lung injury; chronic lung injury; host pathogen interactions; viral infections; bacterial infections; lung cancer; anti-vimentin antibodies

资金

  1. NIEHS [P42 ES027723]
  2. NIH [R01 18 ES029981]

向作者/读者索取更多资源

This review discusses the role of vimentin intermediate filaments beyond being a marker for epithelial to mesenchymal transition (EMT), focusing on their role as regulators of host-pathogen interactions and signaling pathways in the pathophysiology of various lung diseases.
Vimentin intermediate filaments, a type III intermediate filament, are among the most widely studied IFs and are found abundantly in mesenchymal cells. Vimentin intermediate filaments localize primarily in the cytoplasm but can also be found on the cell surface and extracellular space. The cytoplasmic vimentin is well-recognized for its role in providing mechanical strength and regulating cell migration, adhesion, and division. The post-translationally modified forms of Vimentin intermediate filaments have several implications in host-pathogen interactions, cancers, and non-malignant lung diseases. This review will analyze the role of vimentin beyond just the epithelial to mesenchymal transition (EMT) marker highlighting its role as a regulator of host-pathogen interactions and signaling pathways for the pathophysiology of various lung diseases. In addition, we will also examine the clinically relevant anti-vimentin compounds and antibodies that could potentially interfere with the pathogenic role of Vimentin intermediate filaments in lung disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据